Vir Biotechnology, Inc. (NASDAQ:VIR) filed a Form 8-K with the Securities and Exchange Commission on February 23, 2026, disclosing a material event.
Vir Biotechnology, Inc.'s stock currently trades at $7.43 with a market capitalization of $923.0M. The Healthcare company's stock moved following the disclosure.